You just read:

Gala Enrolls First Subject at Temple Lung Center as Part of the US Early Feasibility Trial of RheOx™ for Chronic Bronchitis in the United States

News provided by

Gala Therapeutics, Inc.

Jan 17, 2019, 07:00 ET